Dr Reddys Laboratories (RDY) Acquisitions (2015)

Dr Reddys Laboratories (RDY) recorded quarterly Acquisitions of -$125.3 million in Q2 2015.

Dr Reddys Laboratories (RDY) Acquisitions (2015) Analysis & Trends

Dr Reddys Laboratories' Acquisitions history runs 1 years deep, the most recent figure standing at -$125.3 million for Q2 2015.

  • In Q2 2015, Acquisitions changed N/A year-over-year to -$125.3 million; the TTM figure through Dec 2015 stood at -$125.3 million (changed N/A YoY), while the FY2026 annual figure was -$35.7 million, up 94.32% from the prior year.
  • Acquisitions was -$125.3 million for Q2 2015 at Dr Reddys Laboratories.
  • In the past five years, Acquisitions ranged from a high of -$125.3 million in Q2 2015 to a low of -$125.3 million in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.09 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 137.87 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2015 -125.31 Mn